Abstract: Supporting the measurement based on the fair value invokes a series of reasons that conclude that the fair value, as a method of measurement of the future economic benefits that is expected to be generated by the biological assets, has a greater relevance, reliability, comparability and intelligibility that the historic cost, and it is for this reason that we find more biological assets on active markets with clear market prices.